Dynamic Interaction between Fluconazole and Amphotericin B against Cryptococcus gattii

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2012-01-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1128/AAC.06098-11PMID 22290956PMCID PMC3346628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical and Laboratory Standards Institute.

  2013cited by this paper
• Molecular mechanisms involved in the early steps of flavivirus cell entry.

  2011cited by this paper
• Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals.

  2011cited by this paper
• Cryptococcus gattii: In Vitro Susceptibility to Photodynamic Inactivation

  2011cited by this paper
• Correlation of the in vitro antifungal drug susceptibility with the in vivo activity of fluconazole in a murine model of cerebral infection caused by Cryptococcus gattii

  2010cited by this paper
• Antifungal therapy in invasive fungal infections.

  2010cited by this paper
• Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard

  2008influential reference
• Cerebral infection caused by Cryptococcus gattii: a case report and antifungal susceptibility testing.

  2008cited by this paper
• Infección cerebral causada por Cryptococcus gattii: caso clínico y sensibilidad a los antifúngicos

  2008cited by this paper
• Concentration-Dependent Synergy and Antagonism within a Triple Antifungal Drug Combination against Aspergillus Species: Analysis by a New Response Surface Model

  2007cited by this paper
• Establishing a Method of Inoculum Preparation for Susceptibility Testing of Trichophyton rubrum and Trichophyton mentagrophytes

  2006cited by this paper
• In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp.

  2006cited by this paper
• Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.

  2006cited by this paper
• Combined Activity In Vitro of Caspofungin, Amphotericin B, and Azole Agents against Itraconazole-Resistant Clinical Isolates of Aspergillus fumigatus

  2005cited by this paper
• Combination Treatment of Invasive Fungal Infections

  2005cited by this paper
• Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies.

  2005cited by this paper
• Combination Antifungal Therapy

  2004cited by this paper
• Cloning and characterization of the lanosterol 14alpha-demethylase (ERG11) gene in Cryptococcus neoformans.

  2004cited by this paper
• Fluconazole resistance in Candida albicans: a review of mechanisms.

  2004cited by this paper
• Tratamiento de infecciones fúngicas sistémicas Primera parte: fluconazol, itraconazol y voriconazol

  2004cited by this paper
• Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far.

  2003cited by this paper
• In vitro evaluation of combination of terbinafine with itraconazole or amphotericin B against Zygomycota.

  2003cited by this paper
• Synergy, antagonism, and what the chequerboard puts between them.

  2003cited by this paper
• Postantifungal effect and effects of sub-MIC concentrations on previously treated Candida sp. influence of growth phase.

  2002cited by this paper
• Itraconazole-Amphotericin B Antagonism inAspergillus fumigatus: an E-Test-Based Strategy

  2000cited by this paper
• Interactions between Triazoles and Amphotericin B against Cryptococcus neoformans

  2000cited by this paper
• Postantifungal Effects of Echinocandin, Azole, and Polyene Antifungal Agents against Candida albicans andCryptococcus neoformans

  2000cited by this paper
• Quantitation of Ergosterol Content: Novel Method for Determination of Fluconazole Susceptibility of Candida albicans

  1999cited by this paper
• [Cryptococcosis in children in the State of Pará, Brazil].

  1999cited by this paper
• Criptococose em crianças no Estado do Pará, Brasil

  1999cited by this paper
• Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans

  1997cited by this paper

• New Chlorinated Meroterpenoids with Antifungal Activity from the Deep-Sea-Derived Fungus Acremonium sclerotigenum

  2026cites this paper
• Thiazole Derivatives as Promising Candidates for Cryptococcosis Therapy

  2025cites this paper
• Hydroethanolic Extract of Punica granatum Inhibits Cryptococcus by Depolarising Mitochondrial Membranes

  2025cites this paper
• Global Evaluation of Tuberculosis and Cryptococcosis Co-infection: A Systematic Review.

  2025cites this paper
• In vitro and in vivo synergistic antifungal effects of microbially synthesized silver and magnetic iron oxide nanoparticles against Candida albicans

  2025cites this paper
• N(14)-phenyl-substituted evodiamine derivatives for the treatment of superficial fungal infections by inhibiting xanthine dehydrogenase.

  2025cites this paper
• Influence of the agrochemical benomyl on Cryptococcus gattii-plant interaction in vitro and in vivo

  2024cites this paper
• Novel combinatorial approach: Harnessing HIV protease inhibitors to enhance amphotericin B’s antifungal efficacy in cryptococcosis

  2024cites this paper
• Selection of ethanol tolerant strains of Candida albicans by repeated ethanol exposure results in strains with reduced susceptibility to fluconazole

  2024cites this paper
• New miconazole-based azoles derived from eugenol show activity against Candida spp. and Cryptococcus gattii by inhibiting the fungal ergosterol biosynthesis.

  2023cites this paper
• Selection of Ethanol Tolerant Strains of Candida albicans by Repeated Ethanol Exposure Results in Strains with Reduced Susceptibility to Fluconazole

  2023cites this paper
• Antifungal activity of selective serotonin reuptake inhibitors against Cryptococcus spp. and their possible mechanism of action.

  2023cites this paper
• Antimalarials and amphotericin B interact synergistically and are new options to treat cryptococcosis.

  2023cites this paper
• Ethyl Acetate Fraction of Punica granatum and Its Galloyl-HHDP-Glucose Compound, Alone or in Combination with Fluconazole, Have Antifungal and Antivirulence Properties against Candida spp.

  2022cites this paper
• In Silico and In Vitro Analysis of Sulforaphane Anti-Candida Activity

  2022cites this paper
• Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China

  2022cites this paper
• Differential analysis of ergosterol function in response to high salt and sugar stress in Zygosaccharomyces rouxii.

  2022cites this paper
• Nicotiana benthamiana as a model for studying Cryptococcus-plant interaction.

  2022cites this paper
• A Study of the Disruptive Effect of the Acetate Fraction of Punica granatum Extract on Cryptococcus Biofilms

  2021cites this paper
• In vitro synergistic effects of fluoxetine and paroxetine in combination with amphotericin B against Cryptococcus neoformans.

  2021cites this paper
• Synergism of Zinc Oxide Quantum Dots with Antifungal Drugs: Potential Approach for Combination Therapy against Drug Resistant Candida albicans

  2021cites this paper
• Actin cytoskeletal inhibitor 19,20-epoxycytochalasin Q sensitizes yeast cells lacking ERG6 through actin-targeting and secondarily through disruption of lipid homeostasis

  2021cites this paper
• Screening of chemical libraries for new antifungal drugs against Aspergillus fumigatus reveals the potential mechanism of action of miltefosine

  2021cites this paper
• Activity and Mechanism of Action of Antifungal Peptides from Microorganisms: A Review

  2021cites this paper
• Screening of Chemical Libraries for New Antifungal Drugs against Aspergillus fumigatus Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine

  2021cites this paper
• Evaluation of in vitro Antifungal Activity of Xylosma prockia (Turcz.) Turcz. (Salicaceae) Leaves Against Cryptococcus spp.

  2020cites this paper
• Inhibitory effect of magnetic iron-oxide nanoparticles on the pattern of expression of lanosterol 14α-demethylase (ERG11) in fluconazole-resistant colonising isolate of Candida albicans.

  2020cites this paper
• Hypervirulence and cross-resistance to a clinical antifungal are induced by an environmental fungicide in Cryptococcus gattii.

  2020cites this paper
• Mechanisms of interaction of Cetylpyridinium chloride with Staphylococcus aureus in the presence of β-cyclodextrin

  2020cites this paper
• Effect of non-antifungal agrochemicals on the pathogenic fungus Cryptococcus gattii.

  2019cites this paper
• Short-Course Rather Than Low-Dose Amphotericin B May Exert Potential Influence on Mortality in Cryptococcal Meningitis Patients Treated With Amphotericin B Plus Flucytosine Alone or in Combination With Fluconazole

  2019cites this paper
• Synergistic antifungal interactions of amphotericin B with 4-(5-methyl-1,3,4-thiadiazole-2-yl) benzene-1,3-diol

  2019cites this paper
• Terpinen-4-ol inhibits the growth of Sporothrix schenckii complex and exhibits synergism with antifungal agents.

  2019cites this paper
• O uso de pCramoll como tratamento da criptococose em camundongos imunocompetentes e imunossurimidos

  2019cites this paper
• From the environment to the host: How non-azole agrochemical exposure affects the antifungal susceptibility and virulence of Cryptococcus gattii.

  2019cites this paper
• Transitions in interaction landscapes of multidrug combinations

  2018cites this paper
• Undiagnosed Cryptococcus gattii meningitis leading to subsequent ventriculoperitoneal shunt infection in a patient with symptoms of normal pressure hydrocephalus: case report and literature review

  2018cites this paper
• Control of Cryptococcus Gattii Biofilms by an Ethanolic Extract of Cochlospermum Regium (Schrank) Pilger Leaves

  2018cites this paper
• Transcriptional Heterogeneity of Cryptococcus gattii VGII Compared with Non-VGII Lineages Underpins Key Pathogenicity Pathways

  2018cites this paper
• Antifungal Activity of Carvacrol on Ergosterol Synthesis in Multidrug Resistant Candida albicans

  2018cites this paper
• Analysis of ergosterol and gene expression profiles of sterol Δ5,6-desaturase (ERG3) and lanosterol 14α-demethylase (ERG11) in Candida albicans treated with carvacrol

  2018cites this paper
• Avaliação da atividade antifúngica in vitro das folhas de Xylosma ciliatifolia (Clos) Eichler (Salicaceae) frente a linhagens de Cryptococcus gattii e Cryptococcus neoformans

  2018cites this paper
• Transcriptional heterogeneity of VGII compared with non-VGII lineages underpins key pathogenicity pathways

  2018cites this paper
• A subdose of fluconazole alters the virulence of Cryptococcus gattii during murine cryptococcosis and modulates type I interferon expression

  2017cites this paper
• Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients

  2017cites this paper
• Quantitation of ergosterol content and gene expression profile of ERG11 gene in fluconazole-resistant Candida albicans

  2017cites this paper
• Environmental Triazole Induces Cross-Resistance to Clinical Drugs and Affects Morphophysiology and Virulence of Cryptococcus gattii and C. neoformans

  2017cites this paper
• Treatment with pCramoll Alone and in Combination with Fluconazole Provides Therapeutic Benefits in C. gattii Infected Mice

  2017cites this paper
• Atorvastatin as a promising anticryptococcal agent.

  2017cites this paper
• High-dose fluconazole in combination with amphotericin B is more efficient than monotherapy in murine model of cryptococcosis

  2017cites this paper
• Eugenol Induces Phenotypic Alterations and Increases the Oxidative Burst in Cryptococcus

  2017cites this paper
• Produção de melanina pelo fungo termodimórfico Paracoccidioides lutzii e análise da melanina como fator de virulência sobre a interface infecção - resposta imune.

  2016cites this paper
• Pharmacokinetics/pharmacodynamic correlations of fluconazole in murine model of cryptococcosis.

  2016cites this paper
• Synergistic effect of pedalitin and amphotericin B against Cryptococcus neoformans by in vitro and in vivo evaluation.

  2016cites this paper
• Transcriptomic analysis of synergy between antifungal drugs and iron chelators for alternative antifungal therapies

  2016cites this paper
• [Combination antifungal therapy for invasive fungal disease in children with hematologic disease].

  2015cites this paper
• Heteroresistance to Itraconazole Alters the Morphology and Increases the Virulence of Cryptococcus gattii

  2015cites this paper
• Thiazole compounds with activity against Cryptococcus gattii and Cryptococcus neoformans in vitro.

  2015cites this paper
• 2-(Benzylideneamino)phenol: A Promising Hydroxyaldimine with Potent Activity Against Dermatophytoses

  2014cites this paper
• Combination antifungal therapy: a strategy for the management of invasive fungal infections.

  2014cites this paper
• Synergy against fungal pathogens: working together is better than working alone.

  2014cites this paper
• Fluconazole Alters the Polysaccharide Capsule of Cryptococcus gattii and Leads to Distinct Behaviors in Murine Cryptococcosis

  2014cites this paper
• The role of oxidative and nitrosative bursts caused by azoles and amphotericin B against the fungal pathogen Cryptococcus gattii.

  2013cites this paper
• Photodynamic inhibition of Trichophyton rubrum: in vitro activity and the role of oxidative and nitrosative bursts in fungal death.

  2013cites this paper
• Imidazolium salts as antifungal agents: activity against emerging yeast pathogens, without human leukocyte toxicity

  2013cites this paper
• Cryptococcosis due to Cryptococcus gattii.

  2013cites this paper